Pinnacle Bancorp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Pinnacle Bancorp's REGN Position: Q2 2026 in Review
Pinnacle Bancorp increased its Regeneron Pharmaceuticals (REGN) stake by 22% in Q2 2026, buying an estimated $2.72K and bringing the position to 22 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #695.
Pinnacle Bancorp first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $13.9K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Pinnacle Bancorp held 22 shares of Regeneron Pharmaceuticals worth $13.7K as of Q2 2026.
- Pinnacle Bancorp bought 4 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q2 2026, its #695 holding.
- Pinnacle Bancorp first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- Pinnacle Bancorp's Regeneron Pharmaceuticals position peaked at $13.9K in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.